Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicalutamide and Everolimus in Hormone-Independent Prostate Cancer
NCT00814788Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Dec 2008
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in prostate cancer (PCa), sponsored by University of California, Davis. Started Dec 2008; status: completed.
02
Drugs
everolimus
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00814788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814788.